With Huge Debts And Divestment Plans, Wockhardt Chairman Habil Khorakiwala Exhorts Employees To Rise To The Challenge

MUMBAI - These are tough times for Habil Khorakiwala, chairman of Wockhardt, one of India's largest pharmaceutical and biotechnology companies, as he deals with the worst financial crisis that any large Indian drug company has faced in the aftermath of the global economic meltdown